Stock Research: Outset Medical

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

Outset Medical

NasdaqGS:OM US6901451079
35
  • Value
    48
  • Growth
    21
  • Safety
    Safety
    84
  • Combined
    50
  • Sentiment
    18
  • 360° View
    360° View
    35
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Outset Medical, Inc. is a medical technology company focused on hemodialysis solutions. Its main business is the Tablo Hemodialysis System, an enterprise solution for hemodialysis that can be used across various care settings. The company operates primarily in the medical technology industry, providing compact, mobile, and versatile dialysis machines with integrated water purification and advanced software. In the last fiscal year, the company had a market cap of $325 million, profits of $39 million, revenue of $114 million, and 354 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 35 (better than 35% compared with alternatives), overall professional sentiment and financial characteristics for the stock Outset Medical are below the industry average. The 360° View is based on consolidating four consolidated indicators, with three out of four indicators below average for Outset Medical. Only the consolidated Value Rank has an attractive rank of 84, which means that the share price of Outset Medical is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means that the stock price is lower than for 84% of alternative stocks in the same industry. All other consolidated ranks are below average. The consolidated Growth Rank has a low rank of 21, which means that the company exhibits below-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. The consolidated Safety Rank has a riskier rank of 48, meaning the company has a riskier financing structure than 52% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. Finally, professionals are more pessimistic about the stock than for 82% of alternative investment opportunities, reflected in the consolidated Sentiment Rank of 18. ...read more

more
Index
NASDAQ
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 13-Nov-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
84 83 63 45
Growth
21 17 23 75
Safety
Safety
48 60 56 49
Sentiment
18 20 23 22
360° View
360° View
35 42 15 42
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
65 68 12 66
Opinions Change
19 50 50 23
Pro Holdings
n/a 24 26 14
Market Pulse
28 19 56 35
Sentiment
18 20 23 22
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
84 83 63 45
Growth
21 17 23 75
Safety Safety
48 60 56 49
Combined
50 63 40 63
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
78 78 78 12
Price vs. Earnings (P/E)
79 95 66 15
Price vs. Book (P/B)
95 87 78 63
Dividend Yield
1 1 1 1
Value
84 83 63 45
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
48 47 63 95
Profit Growth
78 83 68 21
Capital Growth
15 12 3 97
Stock Returns
11 3 9 35
Growth
21 17 23 75
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
6 25 48 60
Refinancing
95 96 89 69
Liquidity
35 24 12 9
Safety Safety
48 60 56 49

Similar Stocks

Discover high‑ranked alternatives to Outset Medical and broaden your portfolio horizons.

Alphabet

NasdaqGS:GOOG.L
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Cognizant Technology

NasdaqGS:CTSH
Country: USA
Industry: IT Consulting & oth. Services
Size: X-Large
Full Stock Analysis

Meta

NasdaqGS:FB
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Cigna

NYSE:CI
Country: USA
Industry: Health Care Services
Size: XX-Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.